IronBridge Private Wealth’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-623
Closed -$33K 147
2021
Q4
$33K Hold
623
0.02% 95
2021
Q3
$44K Hold
623
0.02% 59
2021
Q2
$42K Sell
623
-377
-38% -$26.7K 0.02% 66
2021
Q1
$111K Hold
1,000
0.07% 43
2020
Q4
$119K Buy
+1,000
New +$108K 0.09% 37

Other funds holding HAE

IronBridge Private Wealth's HAE Position: Q1 2022 in Review

IronBridge Private Wealth sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 623 shares — an estimated $33K sold.

IronBridge Private Wealth first reported a position in HAE in Q4 2020 and held it in 5 quarters. The position peaked at $119K in Q4 2020. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.

  • IronBridge Private Wealth reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
  • IronBridge Private Wealth sold 623 Haemonetics shares in Q1 2022, an estimated $33K.
  • IronBridge Private Wealth first reported a position in Haemonetics in Q4 2020 and held it in 5 quarters.
  • IronBridge Private Wealth's Haemonetics position peaked at $119K in Q4 2020.
  • 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.

Based on IronBridge Private Wealth's 13F filing for Q1 2022, filed 16 May 2022.